In addition, we found that patients with higher TRB3, HO-1, PCK2, and xCT expression in gastric cancer under adjuvant chemotherapy treatment have lower PFS and lower OS than patients with lower TRB3, HO-1, PCK2, and xCT expression, respectively (Table 1). The gene discussed is HMOX1; the disease is gastric cancer.